Solesence, Inc. Common Stock (SLSN) Investor Relations Documents

Solesence, Inc. Common Stock (SLSN) investor relations documents from the company's IR site: 1 presentation, 16 press releases; latest deck 2026-05-12. Read in-app with summaries. First-party data.

Q1 2026 Presentation: Solésence Beauty Science Q1 2026 earnings report shows $13.0M in revenue and a net loss of $0.8M as the company executes its 'Transform and Transcend' strategy.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-10Press releaseSolésence Reschedules Second Quarter 2026 Conference Call to August 19
2026-07-28Press releaseSolésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
2026-07-13Press releaseSolésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp
2026-06-18Press releaseSolésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
2026-06-08Press releaseQ1 2026 Press Release
2026-05-19Press releaseSolésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Mark
2026-05-14Press releaseSolésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
2026-05-12PresentationQ1 2026 Presentation
2026-05-12Press releaseSolésence Reports First Quarter 2026 Financial Results
2026-05-11Press releaseSolésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
2026-04-28Press releaseSolésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
2026-04-27Press releaseSolésence, Inc. Announces Appointment of New Independent Director
Press releasePress Release
2026-03-19Press releaseSolésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
Press releasePress Release
Press releasePress Release
Press releasePress Release

SLSN overview · SLSN earnings · SLSN financials · SLSN KPIs · SLSN ownership · SLSN peers · SLSN filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.